A serum microRNA signature is associated with the immune control of chronic hepatitis B virus infection

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Brunetto, Maurizia Rossana ^a   Cavallone, Daniela ^a   Oliveri, Filippo ^a   Moriconi, Francesco ^a   Colombatto, Piero ^a   Coco, Barbara ^a   Ciccorossi, Pietro ^a   Rastelli, Carlotta ^a   Romagnoli, Veronica ^a   Cherubini, Beatrice ^a   Teilum, Maria Wrang ^b   Blondal, Thorarinn ^b   Bonino, Ferruccio ^c  

^a UNIVERSITY HOSPITAL OF PISA   (Italy)

^b Exiqon A/S   (Denmark)

^c UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; MICRORNA; MICRORNA 122 5P; MICRORNA 126; MICRORNA 192 5P; MICRORNA 320A; MICRORNA 335; MICRORNA 99A 5P; NUCLEOTIDE DERIVATIVE; PEGINTERFERON; UNCLASSIFIED DRUG; VIRUS DNA; ANTIVIRUS AGENT;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DOWN REGULATION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GENE OVEREXPRESSION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNITY; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; VIRUS CARRIER; VIRUS PARTICLE; BIOLOGY; BLOOD; CLUSTER ANALYSIS; GENE EXPRESSION PROFILING; GENETICS; HEPATITIS B, CHRONIC; HOST PATHOGEN INTERACTION; IMMUNOLOGY; MIDDLE AGED; REPRODUCIBILITY; VIROLOGY; VIRUS LOAD; YOUNG ADULT;

HEPATITIS B VIRUS;

ADULT; AGED; ANTIVIRAL AGENTS; CLUSTER ANALYSIS; COHORT STUDIES; COMPUTATIONAL BIOLOGY; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION PROFILING; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HOST-PATHOGEN INTERACTIONS; HUMANS; MALE; MICRORNAS; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; VIRAL LOAD; YOUNG ADULT;

EID: 84908565761     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0110782     Document Type: Article

References (34)

1. (2012) EASL-Clinical-Practice-Guidelines: Management of chronic HBV infection, J Hepatol 57: 167-185.
2. Lok ASK, BJ McMahon (2009) Chronic hepatitis B: update 2009. Hepatology 50(3): 661-2.
3. Liaw Y-F, Kao J-H, Piravitvisuth T, Chan HLY, Chien R-N, et al. (2012) Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update. Hepatol Int 6: 531-561.
4. Bonino F, Rosina F, Rizzetto M, Rizzi R, Chiaberge E, et al. (1986) Chronic hepatitis in HBsAg carriers with serum HBV-DNA and Anti-HBe. Gastroenterology90: 1268-73.
5. Brunetto MR, Oliveri F, Coco B, Leandro G, Colombatto P, et al. (2002)Outcome of anti-HBe positive chronic hepatitis B in alpha-interferon treated and untreated patients: a long term cohort study. J Hepatol 36: 263-70.
6. Brunetto MR, Oliveri F, Colombatto P, Moriconi F, Ciccorossi P, et al. (2010) Hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriers. Gastroenterology 139: 483-490.
7. Brunetto MR, Moriconi F, Bonino F, Lau GK, Farci P, et al. (2009) Hepatitis B virus surface antigen levels: a guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B. Hepatology 49: 1141-1150.
8. Janssen HL, Sonneveld MJ, Brunetto MR (2012) Quantification of serum HBsAg: is it useful for the management of chronic hepatitis B? Gut 61: 641-45.
9. Brunetto MR, Marcellin P, Cherubini B, Yurdaydin C, Farci P, et al. (2013) Response to peginterferon alfa-2a (40 KD) in HBeAg-negative CHB: ontreatment kinetics of HBsAg serum levels vary by HBV genotype. J Hepatol 59(6): 1153-9.
10. Ambros V (2004) The functions of animal microRNAs. Nature 431: 350-55.
11. Xiao C, Rajewsky K (2009) MicroRNA Control in the Immune System: Basic Principles. Cell 136: 26-36.
12. Cullen BR (2011) Viruses and microRNAs: RISCy interactions with serious consequences. Genes & Development 25: 1881-94.
13. Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P (2005) Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 309:1577-1581.
14. Novellino L, Rossi RL, Bonino F, Cavallone D, Abrignani S, et al. (2012)Circulating hepatitis B surface antigen particles carry hepatocellular micro-RNAs. PLoS One 7(3): e31952.
15. Hayes CN, Akamatsu S, Tsuge M, Miki D, Akiyama R, et al. (2012) Hepatitis Bvirus-specific miRNAs and Argonaute2 play a role in the viral life cycle. PLoS One 7: e47490.
16. Li LM, Hu ZB, Zhou ZX, Chen X, Liu FY, et al. (2010) Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBVpositive hepatocarcinoma. Cancer Res 70(23): 9798-807.
17. Ji F, Yang B, Peng X, Ding H, You H, et al. (2011) Circulating microRNAs in hepatitis B virus-infected patients. J Viral Hepat 18(7): e242-51.
18. Wang XW, Heegaard NHH, Orum H (2012) MicroRNAs in Liver Disease.Gastroenterology 142: 1431-43.
19. Blondal T, Nielsen JS, Baker A, Andreansen D, Mouritzen P, et al. (2013) Assessing sample and miRNA profile quality in serum and plasma or other biofluids. Methods 59: S1-6.
20. Bustin SA, Benes V, Garson AJ, Hellemans J, Huggett J, et al. (2009) The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments. Clinical Chemistry 55: 611-622.
21. Ramakers C, Ruijter JM, Deprez RHL, Moorman AF (2003) Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data.Neurosci Lett 339(1): 62-66.
22. Ruijter JM, Ramakers C, Hoogaars WM, Karlen Y, Bakker O, et al. (2009) Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR data. Nucleic Acids Res 37: e45.
23. Andersen CL, Ledet-Jensen J, Ørntoft T (2004) Normalization of real-time-quantitative-RT-PCR data: a model based variance estimation approach to identify genes suited for normalization applied to bladder- and colon-cancer data-sets. Cancer Research 64: 5245-50.
24. Mestdagh P, Van Vlierberghe P, De Weer A, Muth D, Westermann F, et al.(2009) A novel and universal method for microRNA RT-qPCR data normalization. Genome Biol 10: R64.
25. Saeed AI, Sharov V, White J, Li J, Liang W, et al. (2003) TM4: a free, opensource system for microarray data management and analysis. Biotechniques34(2): 374-8.
26. Saeed Al, Bhagabati NK, Braisted JC, Liang W, Sharov V, et al. (2006) TM4 microarray software suite. Methods in Enzymology 411: 134-93.
27. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using Real-Time-Quantitative-PCR and the 22DDCT-Method. Methods 25: 402-48.
28. Wang K, Yuan Y, Cho J, McClarty S, Baxter D, et al. (2012) Comparing the microRNA spectrum between serum and plasma. PLoS-One 7: e41561.
29. Hu J, Xu Y, Hao J, Wang S, Li C, et al. (2012) MiR-122 in hepatic function andliver diseases. Protein Cell 3: 364-371.
30. Zhang X, Daucher M, Armistead D, Russel R, Kottilil S (2013) MicroRNA expression profiling in HCV-infected human hepatoma cells identifies potential anti-viral targets induced by interferon- a. PLoS-One. 8: e55733.
31. Cheng M, Si Y, Niu Y, Liu X, Li X, et al. (2013) High-throughput profiling of IFNa and IL-28B regulated microRNAs and identification of let-7s with anti-HCV activity by targeting IGF2BP1. J Virol 87: 9707-18.
32. Li D, Liu X, Lin L, Hou J, Li N, et al. (2011) MicroRNA-99a inhibits hepatocellular carcinoma growth and correlates with prognosis of patients with hepatocellular carcinoma. J Biol Chem 286: 36677-36685.
33. van der Meer AJ, Farid WR, Sonneveld MJ, de Ruiter PE, Boonstra A, et al.(2013) Sensitive detection of hepatocellular injury in chronic hepatitis C patients with circulating hepatocyte-derived microRNA-122. J Viral Hepat 20: 158-166.
34. Hu J, Wang Z, Tan CJ, Liao BY, Zhang X, et al. (2013) Plasma microRNA, a potential biomarker for acute rejection after liver transplantation. Transplantation 95: 991-99.